CRISPR Screening Identifies CDK12 as a Conservative Vulnerability of Prostate Cancer

The authors performed a kinome-scale CRISPR/Cas9 screen and identified cyclin-dependent kinase 12 (CDK12) as being conservatively required for PCa cell survival.